Please login to the form below
Makara Health appoints Louise Finke as a director
She will support the healthcare comms agency’s strategic programme delivery
Healthcare communications and education agency Makara Health has expanded its leadership team with the appointment of Louise Finke as a director.
Finke brings 15 years industry experience from the likes of Shire and Wyeth (now part of Pfizer) to the Southampton, UK-based agency, having previously worked on market access challenges including pre-launch and launch activities.
Louise Sharp, founder and managing director of Makara Health, said: “Finke’s considerable experience, strategic approach and industry knowledge make her a perfect fit for Makara as the company continues to expand.
“I am confident that Louise will support out ongoing success as we move into an exciting 2018.”
COVID-19 Updates and Daily News
Featured jobs
-
Senior Health Psychologist, London
-
Highly competitive salary
- Senior Analyst, Market Access, UK, Home based
-
Highly competitive salary
-
Consultant Dermatologist (Freelance)
-
£110-180ph
-
Head of Health Psychology, London
-
Highly competitive salary
- Senior Account Executive, Medical/ Brand Communications, London
-
Highly competitive salary
- Scientists discover new approach to treat brain tumours
- Boehringer Ingelheim’s pulmonary fibrosis treatment produces promising phase 2 data
- BMA appoints two internal candidates to share the role of chief executive officer
- Taking a holistic approach to patient care
- Almirall and Evotec team up in multi-target dermatology alliance
- AstraZeneca and UK-based biotech company RQ BIO sign licencing agreement
- MadMicrobe Studios Inc Announces New European Venture
- EMA accepts Valneva’s marketing authorisation application for COVID-19 vaccine
- UICC launches global ATOM Coalition to increase access to essential cancer medicines
- Innovative Medical Solutions for Postponing and Undoing Age-Related Disease
- Almirall and Evotec team up in multi-target dermatology alliance
- Moderna wins Prix Galien UK Award for best biotechnology product
- BioXcel Therapeutics begins phase 3 trial for acute agitation in Alzheimer’s patients
- FDA approves Bavarian Nordic’s smallpox and monkeypox vaccine
- Celebrating the power of knowledge on International Thalassaemia Day 2022
- An effective commercial model for cancer care
- BMA appoints two internal candidates to share the role of chief executive officer
- Bristol Myers Squibb releases positive trial results for plaque psoriasis treatment
PMHub
Say Communications
Influencing positive behaviours and delivering change is what drives us, using thought leadership, education, social and professional engagement and compelling,...
Latest intelligence
- Leveraging Real-World Evidence for Cell and Gene Therapies
- Regulators and reimbursement bodies are increasingly turning to real-world evidence (RWE) to understand the long-term value of drugs, in particular novel therapies. Here, Mariam Bibi, Senior Director, Global RWE at...
- Food Allergy – Is avoidance the only option?
- Following on from Allergy Awareness Week 2022, we’re continuing the discussion about food allergies and the experiences of those who live with them. In this blog, we discuss the current...
- Serious about sustainability?
- Get to know our new Sustainability Officer here at Cuttsy+Cuttsy...
